Nicholas Auble, Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave, Spokane, WA 99204 Phone: 509-474-3260 Fax: 509-227-7070 |
Mr. Timothy Michael Chestnut, M.D. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 7209 S. South Meadows Rd, Spokane, WA 99223 Phone: 509-994-5442 Fax: 509-448-8917 |
Daniel Robert Coulston, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 910 W 5th Ave, Suite 1001, Spokane, WA 99204 Phone: 509-838-2531 Fax: 509-755-6580 |
Dr. John K Naylor, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 W 5th Ave, Ste 1001, Spokane, WA 99204 Phone: 509-838-2531 Fax: 509-755-6580 |
Joseph C. Swiggum, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 W 5th Ave, Suite 1001, Spokane, WA 99204 Phone: 509-838-2531 Fax: 509-755-6580 |
Todd Robert Green, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 212 E Central Ave, Suite 315, Spokane, WA 99208 Phone: 509-465-3919 Fax: 509-468-0705 |
Dr. Sami Imran Amjad, M.D. Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 104 W 5th Ave, Spokane, WA 99204 Phone: 509-353-3960 |
News Archive
CEA-Leti, coordinator of the European HELIOS project to accelerate commercialization of silicon photonics, said today project partners demonstrated a laser and a 10Gb/s silicon modulator using a process that is compatible with complementary metal-oxide semiconductor (CMOS) processing.
Freescale Semiconductor today announced the newest addition to its growing Kinetis 32-bit microcontroller (MCU) line - the Kinetis K50 family. This new family, targeted for medical and industrial applications, further expands the industry's most extensive and scalable portfolio built on the ARM® Cortex™-M4 core.
Chromatrap has published a new article that describes a detailed genome wide comparison of native and crosslinked chromatin immunoprecipitation followed by next generation sequencing (ChIP-seq) using the company's patented solid state spin column technology.
Inviragen, a biotechnology company developing vaccines to protect against infectious diseases worldwide, together with investigators at the University of Texas Medical Branch (UTMB) and the Division of Vector Borne Diseases (DVBD) of the Centers for Disease Control and Prevention, will make an oral presentation today at the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting on preclinical results of the Company's experimental chikungunya virus (CHIKV) vaccine.
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
› Verified 2 days ago